Vaishakhi Trivedi
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in THRA, a Potential Modifier of Cellular Plasticity.
Journal: JCO global oncology
Published: July 17, 2025
RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.
Journal: JCO precision oncology
Published: May 16, 2024
Association of Cutibacterium acnes with human thyroid cancer.
Journal: Frontiers in endocrinology
Published: January 27, 2023
Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation.
Journal: Translational oncology
Published: February 11, 2022
Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer.
Journal: South Asian journal of cancer
Published: January 21, 2020
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 15, 2019
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis.
Journal: Lung Cancer (Auckland, N.Z.)
Published: February 19, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.
Journal: EClinicalMedicine
Published: October 24, 2018
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomes.
Journal: Ecancermedicalscience
Published: October 21, 2018
Last Updated: 09/26/2026